E-LIB Suche - Ergebnisse für: Kerr, Rachel S

1

Accounting for intensity variation in image analysis of lar..:

Frei, Anja L ; McGuigan, Anthony ; Sinha, Ritik RAK...
The Journal of Pathology: Clinical Research. 9 (2023) 6 - p. 449-463 , 2023

Link: https://doi.org/10.1002/..

2

478 NON-CANONICAL ACTIVIN A SIGNALING STIMULATES CONTEXTDEP..:

Wiley, Mark B. ; Bauer, Jessica ; Mehrotra, Kunaal...
Gastroenterology. 164 (2023) 6 - p. S-95-S-96 , 2023

Link: https://doi.org/10.1016/..

3

Non-Canonical Activin A Signaling Stimulates Context-Depend..:

Wiley, Mark B. ; Bauer, Jessica ; Mehrotra, Kunaal...
Cancers. 15 (2023) 11 - p. 3003 , 2023

Link: https://doi.org/10.3390/..

4

The Influence of Activin on the Tumor Microenvironment in C..:

Wiley, Mark B. ; Bauer, Jessica ; Mehrotra, Kunaal...
The FASEB Journal. 36 (2022) S1 - p. , 2022

Link: https://doi.org/10.1096/..

5

Sa1090: THE INFLUENCE OF ACTIVIN ON THE TUMOR MICROENVIRONM..:

Mehrotra, Kunaal ; Bauer, Jessica ; Zessner-Spitzenberg, Jasmin...
Gastroenterology. 162 (2022) 7 - p. S-300-S-301 , 2022

Link: https://doi.org/10.1016/..

6

The value of additional bevacizumab in patients with high-r..:

Huijbers, Anouck ; van Pelt, Gabi W. ; Kerr, Rachel S....
Journal of Surgical Oncology. 117 (2018) 5 - p. 1043-1048 , 2018

Link: https://doi.org/10.1002/..

7

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine ..:

Iveson, Timothy J ; Kerr, Rachel S ; Saunders, Mark P...
The Lancet Oncology. 19 (2018) 4 - p. 562-578 , 2018

Link: https://doi.org/10.1016/..

8

SCOT: a comparison of cost-effectiveness from a large rando..:

Robles-Zurita, José ; Boyd, Kathleen A. ; Briggs, Andrew H....
British Journal of Cancer. 119 (2018) 11 - p. 1332-1338 , 2018

Link: https://doi.org/10.1038/..

9

Non-Canonical Activin A Signaling Stimulates Context-Depend..:

Wiley, Mark B ; Bauer, Jessica ; Mehrotra, Kunaal...
qt72f8f8b5. , 2023

Link: https://escholarship.org..

10

Accounting for intensity variation in image analysis of lar..:

Frei, Anja L ; McGuigan, Anthony ; Sinha, Ritik RAK...
https://eprints.gla.ac.uk/306875/1/306875.pdf. , 2023

Link: https://eprints.gla.ac.u..

11

3-month versus 6-month adjuvant chemotherapy for patients w..:

Iveson, Timothy ; Boyd, Kathleen A ; Kerr, Rachel S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936167/. , 2019

Link: http://www.ncbi.nlm.nih...

12

SCOT: a comparison of cost-effectiveness from a large rando..:

Robles-Zurita, Jose Antonio ; Boyd, Kathleen A ; Briggs, Andrew H...
http://eprints.gla.ac.uk/167742/1/167742.pdf. , 2018

Link: http://eprints.gla.ac.uk..

13

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine ..:

Iveson, Timothy J ; Kerr, Rachel S ; Saunders, Mark P...
https://researchonline.lshtm.ac.uk/id/eprint/4660627/1/1-s2.0-S1470204518300937-main.pdf. , 2018

Link: https://researchonline.l..

14

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine ..:

Iveson, Timothy J ; Kerr, Rachel S ; Saunders, Mark P...
The Lancet Oncology, 1470-2045, 2018, 19:4, s. 562-578. , 2018

Link: http://urn.kb.se/resolve..

15

SCOT:a comparison of cost-effectiveness from a large random..:

Robles-Zurita, José ; Boyd, Kathleen A ; Briggs, Andrew H...
Robles-Zurita , J , Boyd , K A , Briggs , A H , Iveson , T , Kerr , R S , Saunders , M P , Cassidy , J , Hollander , N H , Tabernero , J , Segelov , E , Glimelius , B , Harkin , A , Allan , K , McQueen , J , Pearson , S , Waterston , A , Medley , L , Wilson , C , Ellis , R , Essapen , S , Dhadda , A S , Hughes , R , Falk , S , Raouf , S , Rees , C , Olesen , R K , Propper , D , Bridgewater , J , Azzabi , A , Farrugia , D , Webb , A , Cunningham , D , Hickish , T , Weaver , A , Gollins , S , Wasan , H S & Paul , J 2018 , ' SCOT : a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer ' , British Journal of Cancer , vol. 119 , no. 11 , pp. 1332-1338 . https://doi.org/10.1038/s41416-018-0319-z. , 2018

Link: https://research.monash...